Dihydroergotamine shortage status
No active shortage currently reported by the regulators Mederti tracks.
- Generic name (INN)
- Dihydroergotamine
- Brand names
- Dihydroergotamine Mesylate Injection, solution for injection, USP
- ATC code
- N02CA01
- Class
- Canonical INN head (inn_resolution)
Frequently asked questions
Is Dihydroergotamine currently in shortage?
No active shortage of Dihydroergotamine is currently reported by any of the national medicines regulators Mederti tracks. Shortages can emerge quickly — this page updates daily from official sources.
Where does this Dihydroergotamine shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Related medicines
Zolmitriptan · Erenumab · Eletriptan · Rizatriptan · Sumatriptan-Succinate · Almotriptan
Get alerted when Dihydroergotamine status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.